RMS-YMHomo sapiens (Human)Cancer cell line

Also known as: RMSYM

AI Summary

No AI-generated summary available for this cell line.

Basic Information

Database IDCVCL_A792
SpeciesHomo sapiens (Human)
Tissue SourceUrachus[UBERON:UBERON_0002068]

Donor Information

Age2
Age CategoryPediatric
SexMale

Disease Information

DiseaseEmbryonal rhabdomyosarcoma
LineageSoft Tissue
SubtypeEmbryonal Rhabdomyosarcoma
OncoTree CodeERMS

DepMap Information

Source TypeRIKEN
Source IDACH-002048_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleBCORp.Arg1163Ter (c.3487C>T)Homozygous-Unknown

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X,Y
CSF1PO
11
D13S317
10,11
D16S539
11
D5S818
12,14
D7S820
10,11
TH01
9
TPOX
11
vWA
18
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Human rhabdomyosarcoma cell lines for rhabdomyosarcoma research: utility and pitfalls.

Linardic C.M.

Front. Oncol. 3:183.1-183.12(2013).

Cetuximab promotes anticancer drug toxicity in rhabdomyosarcomas with EGFR amplification in vitro.

Kitagawa Y., Morikawa Y., Kuroda T.

Oncol. Rep. 30:1081-1086(2013).

Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development.

Pritchard-Jones K., Kool M., Shipley J.M.

Genes Chromosomes Cancer 48:455-467(2009).

Cytogenetic and cellular characteristics of a human embryonal rhabdomyosarcoma cell line, RMS-YM.

Yamada K.

Br. J. Cancer 63:879-884(1991).